PHARMA
Singapore’s First Influenza Vaccine Shows Favorable Immunogenicity
Singapore first influenza vaccine has met its primary endpoint for immunogenicity in the Phase 1 clinical trial in healthy Asian volunteers.
AstraZeneca To Partner Shanghai Institutes In Cardiovascular Diseases Research
AstraZeneca and the Shanghai Institutes of Biological Sciences have signed an agreement to collaborate in cardiovascular disease research.
Biocon, Advaxis To Develop Cancer Immunotherapy Against HPV
Biocon and Advaxis will co-develop and commercialize ADXS-HPV, a novel cancer immunotherapy for the treatment of HPV.
Clinical Trial To Test Renal Denervation In Heart Failure
Doctors at the National University Health System in Singapore are testing a new approach for managing and treating patients with heart failure.
Takeda’s ADCETRIS® Approved For Lymphoma Treatment In Japan
Takeda's ADCETRIS® has been approved for the treatment of patients with certain types of lymphoma in Japan.
Takeda To Sell BIKEN’s Chickenpox Vaccine
Takeda has announced a sales agreement with BIKEN to commence the sale of BIKEN's chickenpox vaccine in Japan from February 2014.
Kunshan RiboQuark Receives Series A Funding For QPI-1007
Kunshan RiboQuark Pharmaceutical Technology has raised nearly RMB 45 million in a series A financing round to accelerate the clinical development of QPI-1007.
Zynex Distributes NeuroMove Device In China
Zynex Medical has signed a five-year agreement with DIH Medical Technologies to distribute its NeuroMove device in China.
Eddingpharm Acquires Small Molecule Drug Assets From ACT Biotech
Eddingpharm has signed an asset purchase agreement with ACT Biotech to acquire worldwide rights to its three small molecule drug assets Telatinib, ACTB1003 and ACTB1010.
